ACS chemical neuroscience molecule spotlight on savella

Research output: Contribution to journalShort survey

Abstract

Savella (milnacipran), a selective serotonin and noradrenaline reuptake inhibitor, was approved by the FDA on January 14th, 2009, for the treatment of fibromyalgia.

Original languageEnglish (US)
Number of pages1
JournalACS Chemical Neuroscience
Volume1
Issue number5
DOIs
StatePublished - May 19 2010

Fingerprint

Neurosciences
Molecules
Fibromyalgia
Serotonin Uptake Inhibitors
milnacipran
Serotonin and Noradrenaline Reuptake Inhibitors

ASJC Scopus subject areas

  • Physiology
  • Biochemistry
  • Cognitive Neuroscience
  • Cell Biology

Cite this

ACS chemical neuroscience molecule spotlight on savella. / Hopkins, Corey R.

In: ACS Chemical Neuroscience, Vol. 1, No. 5, 19.05.2010.

Research output: Contribution to journalShort survey

@article{ec6c4a7c40c74518bcca76c07679d260,
title = "ACS chemical neuroscience molecule spotlight on savella",
abstract = "Savella (milnacipran), a selective serotonin and noradrenaline reuptake inhibitor, was approved by the FDA on January 14th, 2009, for the treatment of fibromyalgia.",
author = "Hopkins, {Corey R}",
year = "2010",
month = "5",
day = "19",
doi = "10.1021/cn1000233",
language = "English (US)",
volume = "1",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - ACS chemical neuroscience molecule spotlight on savella

AU - Hopkins, Corey R

PY - 2010/5/19

Y1 - 2010/5/19

N2 - Savella (milnacipran), a selective serotonin and noradrenaline reuptake inhibitor, was approved by the FDA on January 14th, 2009, for the treatment of fibromyalgia.

AB - Savella (milnacipran), a selective serotonin and noradrenaline reuptake inhibitor, was approved by the FDA on January 14th, 2009, for the treatment of fibromyalgia.

UR - http://www.scopus.com/inward/record.url?scp=77953299584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953299584&partnerID=8YFLogxK

U2 - 10.1021/cn1000233

DO - 10.1021/cn1000233

M3 - Short survey

VL - 1

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 5

ER -